Critical Outcome Technologies Inc (COT.V) Quote| Reuters.com
Edition:
United States

Critical Outcome Technologies Inc (COT.V)

COT.V on TSX Venture Exchange

0.66CAD
29 Jun 2016
Change (% chg)

-- (--)
Prev Close
$0.66
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
202,671
52-wk High
$0.90
52-wk Low
$0.19

COT.V

Chart for COT.V

About

Critical Outcome Technologies Inc. (COTI) is a Canada-based clinical-stage biopharmaceutical company. The Company uses machine learning to develop targeted therapies. The Company's business is disease-specific drug discovery, optimization and pre-clinical development using a developed series of computer models. Its artificial... (more)

Overall

Beta: 0.88
Market Cap(Mil.): $97.17
Shares Outstanding(Mil.): 148.27
Dividend: --
Yield (%): --

Financials

  COT.V Industry Sector
P/E (TTM): -- 39.54 34.69
EPS (TTM): -0.03 -- --
ROI: -136.01 -6.70 14.13
ROE: -136.01 -6.13 15.35

BRIEF-Critical Outcome Tech appoints Alison Silva as new president

* Appointment of alison silva as new president of company effective july 5, 2016

Jun 15 2016

BRIEF-Critical Outcome Activates Second Clinical Trial Site for Its COTI-2 Gynecological Cancer Study

* Critical Outcome Activates Second Clinical Trial Site for Its COTI-2 Gynecological Cancer Study Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Jun 06 2016

Earnings vs. Estimates